Related Experiment Video
Updated: Sep 6, 2025

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Indications, Complications, and Outcomes of Cardiac Surgery After Heart Transplantation: Results From the Cash Study
Johannes Gökler1, Arezu Z Aliabadi-Zuckermann1, Alexandra Kaider2
1Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
Insights
Cardiac surgery after heart transplantation (CASH) is safe for carefully selected patients, showing low in-hospital mortality and manageable complications. This multicenter study highlights the varying incidence and types of CASH globally, with higher EuroSCORE II and renal failure indicating worse outcomes.
Area of Science:
- Cardiology
- Transplantation Medicine
- Cardiac Surgery
Background:
- Allograft pathologies like valvular, coronary artery, or aortic disease can occur post-cardiac transplantation.
- Cardiac surgery after heart transplantation (CASH) may improve quality of life, allograft function, and survival.
- Limited single-center data exists on the experience and outcomes of CASH.
Purpose of the Study:
- To evaluate the safety and outcomes of cardiac surgery after heart transplantation (CASH) in a multicenter setting.
- To identify indications, complications, and survival rates associated with CASH.
- To explore variations in CASH incidence and types across international centers.
Main Methods:
- Retrospective, multicenter study of heart transplant recipients undergoing CASH between January 1984 and December 2020.
- Data collected from 19 participating high-volume cardiac transplant centers across North America, South America, and Europe.
- Analysis included patient demographics, indications for surgery, time from transplant, perioperative complications, and survival.
Main Results:
- A total of 110 patients underwent CASH, with valvular disease being the most common indication (n=62).
- In-hospital mortality was 9.1%, with 1-year survival at 86.2% and a median follow-up of 8.2 years.
- Frequent complications included acute kidney injury (18%) and bleeding revision (9.1%); higher EuroSCORE II and postoperative renal failure were associated with worse outcomes.
Conclusions:
- Cardiac surgery after heart transplantation demonstrates low in-hospital mortality and acceptable postoperative complications in carefully selected patients.
- Significant international variation exists in the incidence and types of CASH performed.
- Higher European System for Cardiac Operative Risk Evaluation (EuroSCORE II) and postoperative renal failure are risk factors for adverse outcomes.
Background:
Allograft pathologies, such as valvular, coronary artery, or aortic disease, may occur early and late after cardiac transplantation. Cardiac surgery after heart transplantation (CASH) may be an option to improve quality of life and allograft function and prolong survival. Experience with CASH, however, has been limited to single-center reports.
Methods:
We performed a retrospective, multicenter study of heart transplant recipients with CASH between January 1984 and December 2020. In this study, 60 high-volume cardiac transplant centers were invited to participate.
Results:
Data were available from 19 centers in North America (n = 7), South America (n = 1), and Europe (n = 11), with a total of 110 patients. A median of 3 (IQR 2-8.5) operations was reported by each center; five centers included ≥ 10 patients. Indications for CASH were valvular disease (n = 62), coronary artery disease (CAD) (n = 16), constrictive pericarditis (n = 17), aortic pathology (n = 13), and myxoma (n = 2). The median age at CASH was 57.7 (47.8-63.1) years, with a median time from transplant to CASH of 4.4 (1-9.6) years. Reoperation within the first year after transplantation was performed in 24.5%. In-hospital mortality was 9.1% (n = 10). 1-year survival was 86.2% and median follow-up was 8.2 (3.8-14.6) years. The most frequent perioperative complications were acute kidney injury and bleeding revision in 18 and 9.1%, respectively.
Conclusion:
Cardiac surgery after heart transplantation has low in-hospital mortality and postoperative complications in carefully selected patients. The incidence and type of CASH vary between international centers. Risk factors for the worse outcome are higher European System for Cardiac Operative Risk Evaluation (EuroSCORE II) and postoperative renal failure.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Kidney Transplant I: Introduction
Cardiomyopathy V: Interprofessional Care
Kidney Transplant II: Surgical Procedure

